Corient Private Wealth
CLX icon

Corient Private Wealth’s Clorox CLX Stock Holding History

Corient Private Wealth’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.81M Buy
71,391
+47,950
+205% +$4.6M 0.01% 780
2026
Q1 		$2.38M Buy
23,441
+7,758
+49% +$880K ﹤0.01% 1172
2025
Q4 		$1.58M Sell
15,683
-2,101
-12% -$228K ﹤0.01% 1268
2025
Q3 		$2.19M Sell
17,784
-3,042
-15% -$378K ﹤0.01% 1020
2025
Q2 		$2.5M Sell
20,826
-4,332
-17% -$578K ﹤0.01% 940
2025
Q1 		$3.7M Sell
25,158
-3,494
-12% -$534K 0.01% 771
2024
Q4 		$4.65M Buy
28,652
+317
+1% +$51.9K 0.01% 722
2024
Q3 		$4.62M Sell
28,335
-872
-3% -$129K 0.01% 776
2024
Q2 		$3.99M Sell
29,207
-2,336
-7% -$324K 0.01% 773
2024
Q1 		$4.83M Sell
31,543
-2,027
-6% -$303K 0.01% 712
2023
Q4 		$4.79M Buy
33,570
+2,230
+7% +$297K 0.01% 705
2023
Q3 		$4.11M Sell
31,340
-213
-0.7% -$32.4K 0.01% 683
2023
Q2 		$5.02M Sell
31,553
-1,927
-6% -$311K 0.01% 634
2023
Q1 		$5.3M Buy
33,480
+6,354
+23% +$953K 0.01% 578
2022
Q4 		$3.81M Buy
+27,126
New +$3.85M 0.01% 558

Other funds holding CLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Corient Private Wealth's CLX Position: Q2 2026 in Review

Corient Private Wealth increased its Clorox (CLX) stake by 205% in Q2 2026, buying an estimated $4.6M and bringing the position to 71,391 shares worth $6.81M. The position accounts for 0.01% of the portfolio, ranked #780.

Corient Private Wealth first reported a position in CLX in Q4 2022 and has held it in 15 quarters since. 1,051 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Corient Private Wealth held 71,391 shares of Clorox worth $6.81M as of Q2 2026.
  • Corient Private Wealth bought 47,950 Clorox shares in Q2 2026, an estimated $4.6M.
  • Clorox made up 0.01% of Corient Private Wealth's portfolio in Q2 2026, its #780 holding.
  • Corient Private Wealth first reported a position in Clorox in Q4 2022 and has held it in 15 quarters since.
  • 1,051 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.